These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10167167)

  • 1. Access to investigational treatments.
    Ader M
    Health Matrix Clevel; 1996; 6(1):187-99. PubMed ID: 10167167
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigational treatments: coverage, controversy, and consensus.
    Ader M
    Ann Health Law; 1996; (5):45-60. PubMed ID: 10164521
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursing new technologies: why are the courts judging experimental medicine?
    Saver RS
    Stanford Law Rev; 1992 May; 44(5):1095-131. PubMed ID: 10119850
    [No Abstract]   [Full Text] [Related]  

  • 4. Funding innovative medical treatment.
    Holder AR
    Albany Law Rev; 1994; 57(3):795-810. PubMed ID: 11652865
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical insurance payments and patients involved in research.
    Holder AR
    IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323
    [No Abstract]   [Full Text] [Related]  

  • 6. Health care providers, insurers, and individual patients; the right to treatment; economic and policy issues.
    Stoddard JC; Billings PR; Astrue MJ; Tennenbaum D; Lynch EC
    Suffolk Univ Law Rev; 1993; 27(4):1499-523. PubMed ID: 11657047
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 9. Insurance coverage for experimental technologies.
    Steinberg EP; Tunis S; Shapiro D
    Health Aff (Millwood); 1995; 14(4):143-58. PubMed ID: 8690340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging technologies and medical coverage.
    Merrikin K; Smith S
    Clin Ethics Rep; 1996; 10(1):9-12. PubMed ID: 11660222
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining experimental therapy--a third-party payer's dilemma.
    Newcomer LN
    N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
    [No Abstract]   [Full Text] [Related]  

  • 12. Reimbursement disputes involving experimental medical treatment.
    Molino PJ
    J Health Hosp Law; 1991 Nov; 24(11):329-36, 343, 359. PubMed ID: 10114834
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparing for the introduction of new technologies: who is going to pay for them?
    Marshall PR
    J Cardiovasc Manag; 2002; 13(1):14-20. PubMed ID: 11828780
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring technological competence and leadership in medicine.
    McGivney WT
    Physician Exec; 1993; 19(1):50-1. PubMed ID: 10125939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of assuring continued post-trial access to beneficial treatment.
    Grady C
    Yale J Health Policy Law Ethics; 2005; 5(1):425-35. PubMed ID: 15742586
    [No Abstract]   [Full Text] [Related]  

  • 16. Forum on prisoners' access to clinical trials: summary of recommendations.
    Stein GL; Headley LD
    AIDS Public Policy J; 1996; 11(1):3-20. PubMed ID: 10915234
    [No Abstract]   [Full Text] [Related]  

  • 17. The mandate for investigational cancer therapies.
    Brown E
    Physician Exec; 1995 Sep; 21(9):46-7. PubMed ID: 10151483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undefined experimental treatment exclusions in health insurance contracts: a proposal for judicial response.
    Belk J
    Wash Law Rev; 1991 Jul; 66(3):809-30. PubMed ID: 11652624
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical technology and the reimbursement dilemma.
    Dragalin D
    Internist; 1992 Oct; 33(9):12-4. PubMed ID: 10121371
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical-trials bottleneck.
    Russo F
    Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.